Christopher Zosh

Direttore Finanziario/CFO presso STATERA BIOPHARMA, INC.

48 anni

Health Technology

Consumer Services

Profilo

Christopher Zosh is currently the Director at Panacela Labs, Inc. since 2017 and the VP, Chief Financial & Accounting Officer at Statera Biopharma, Inc. since 2014.
Previously, he worked at Cleveland BioLabs, Inc. as the CAO, Chief Executive & Financial Officer from 2019 to 2021.
Mr. Zosh completed his undergraduate degree at the State University of New York at Buffalo.

Posizioni attive di Christopher Zosh

Società	Posizione	Inizio
STATERA BIOPHARMA, INC.	Direttore Finanziario/CFO	27/05/2022
Panacela Labs, Inc. Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY.	Direttore/Membro del Consiglio	01/07/2017

Tutte le posizioni attive di Christopher Zosh

Precedenti posizioni note di Christopher Zosh

Società	Posizione	Fine
STATERA BIOPHARMA, INC.	Amministratore Delegato	27/07/2021

Vedi nel dettaglio l'esperienza di Christopher Zosh

Formazione di Christopher Zosh

State University of New York at Buffalo

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Zosh

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
STATERA BIOPHARMA, INC.	Health Technology

Aziende private	2
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.	Health Technology
Panacela Labs, Inc. Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY.	Health Technology